Sunday, December 5, 2021
Home Tags IDMA

Tag: IDMA

Para 19 of DPCO: IDMA urges Govt to allow Pharma industry...

DMA urges Govt to allow Pharma industry to hike Drugs Prices The Indian Drug Manufacturers’ Association (IDMA) has...

NPC: Pharma Companies to adopt these energy conservation measures

As the power crisis is looming large over several states due to shortage of coal, the National Productivity Council (NPC) has called...

Pharma sector needs Government push: IDMA

Government support is needed on various tax benefits for innovation and research in the pharma manufacturing space, says Daara B Patel, Secretary General,...

Ceiling Prices of drugs: Govt takes measures to mandatorily revise ...

The Department of Pharmaceuticals, under the Ministry of Chemicals and Fertilizers, has decided that the ceiling price for formulations specified under SCHEDULE...

PLI Scheme: Govt re-invites applications to Mfr Erythromycin

The Department of Pharmaceuticals (DoP) has re-invited applications from eligible applicants to manufacture fermentation based key starting material/drug intermediate erythromycin thiocyanate under...

Industry urges IPC to defer implementation of IP 2018 Addendum 2021

The drug industry has appealed to Indian Pharmacopoeia Commission (IPC) to defer the implementation of Indian Pharmacopoeia 2018 Addendum 2021 by six...

Pharma Ind appeals to DoP to keep new PLI scheme open...

The drug industry has appealed to the Department of Pharmaceuticals (DoP) to allow all active pharmaceutical ingredients (APIs) / intermediates under category...

Shortage of containers hits exports of pharmaceuticals from India

Exports of pharmaceutical products from India, especially from south Indian ports, have badly hit due to severe shortage of containers which are...

Parameters for evaluating FDCs should be changed: IDMA

The Sub-committee of Drugs Technical and Advisory Board (DTAB) is examining the fixed-dose combinations (FDCs) which are considered irrational by Prof Kokate...

Pharma stakeholders raise concerns about price increase of PVC granules

The rising prices of PVC granules in India are adversely affecting finished formulations of pharma products and it is also affecting the...

NPPA’s remark on approval of FDCs

The National Pharmaceutical Pricing Authority (NPPA)’s remark against approval of fixed dose combination (FDC) drugs has drawn flak from pharmaceutical industry.

Committee to identify investment opportunities, bottlenecks in pharma industry: DoP

Committee to identify investment opportunities, bottlenecks in pharma industry The Department of Pharmaceuticals (DoP) has created a six-member expert...

DoP issues letter to Pharma Associations to ensure adherence to UCPMP

The Department of Pharmaceutical (DoP) has issued a letter to the pharma industry’s key associations, namely; IDMA, BDMA, IPA, OPPI and FOPE...

Amend D&C Act to make marketers also liable for drug quality:...

The Indian Drug Manufacturers’ Association (IDMA) has appealed to the Central Drugs Standard Control Organisation (CDSCO) to amend Section 19(3) of Drugs...

Discussion on regulatory roadmap for pharma industry

There is a need for clear cut research and development policies in the Indian regulatory system, said Eswara Reddy, Joint Drug Controller...

Incentives not enough, API industry seeks more: FOPE

Even as the government hopes to see a tremendous response for its production linked incentive (PLI) scheme for greenfield bulk drug manufacturing projects,...

No shortage of APIs and formulations in the country: Govt

New Delhi: The National Pharmaceutical Pricing Authority (NPPA) has been assured by pharma industry body IDMA that there is no shortage of...

Pharma Cos ask Govt to lift API’s export restrictions

NEW DELHI: Pharmaceutical lobby groups have urged the government to lift restrictions on export of active pharmaceutical ingredients (APIs) and formulations, saying...

Govt mulls export ban on 12 essential drugs

NEW DELHI: Around 12 medicines — mainly antibiotics, vitamins and hormones — may face export restrictions soon as the government explores measures...

Indian pharma Cos want Chinese imports tested 

Worried by the spread of deadly coronavirus (COVID-19), Indian pharma companies have asked the government to set up a mechanism under which...

IDMA urges DCGI to continue with Rs.15k registration fee for 83...

The Indian Drug Manufacturers Association (IDMA) has urged the Drugs Controller General of India (DCGI) asking registration fees of Rs 15,000 to...

Pharma Cos Seek hike in drug rates

With a 50-200% rise in the cost of raw materials imported from China, pharmaceutical lobby groups have urged the government to invoke...

Pharma Cos agrees to cap margins on non-price control drugs at...

NEW DELHI: The domestic drug industry and trade have agreed to the government’s proposal to cap trade margins for all medicines outside price control at 30%, a move...

Gujarat is FAST regaining its lost share in pharma

HG Koshia commissioner, Gujarat Food and Drug Control Authority, Gujarat, is a busy man. The reason is that ever since Goods and Services Tax...

Latest posts

NPPA fixes retail price of 2 formulations: November 2021

Download the notification: The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices of two (2) formulations under the Drugs (Prices Control)...

Authors

59 POSTS0 COMMENTS
30 POSTS0 COMMENTS
20 POSTS0 COMMENTS
15 POSTS0 COMMENTS
11 POSTS0 COMMENTS
9 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
4 POSTS0 COMMENTS
4 POSTS0 COMMENTS
3 POSTS0 COMMENTS
2 POSTS0 COMMENTS
2 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS